Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


vohnetwork.com > news > precision-medicine > enhertu-plus-pertuzumab-approved-in-eu-for-first-line-her2-positive-metastatic-breast-cancer

Enhertu Plus Pertuzumab Approved in EU

1+ week, 5+ day ago   (42+ words) for First-Line HER2-Positive Metastatic Breast Cancer Voice of Healthcare The first new first-line regimen in more than a decade reduces the risk of disease progression or death by 44%, with median progression-free survival reaching 40.7 months....


vohnetwork.com > news > medical-devices > abbott-receives-fda-authorization-for-world-s-first-dual-glucose-ketone-sensing-technology

Abbott Gets FDA Nod for Dual Glucose-Ketone Tech

2+ week, 5+ day ago   (31+ words) Voice of Healthcare Libre Duo 10 Day combines continuous glucose monitoring with ketone tracking to help detect rising levels linked to diabetic ketoacidosis...